No black box warning on record for Sulfamethoxazole And Trimethoprim

As of the latest FDA labeling reviewed, Sulfamethoxazole And Trimethoprim (SULFAMETHOXAZOLE AND TRIMETHOPRIM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sulfamethoxazole And Trimethoprim medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole and trimethoprim is used during pregnancy, or if the patient b

No black box warning on record for Sulfamethoxazole And Trimethoprim

Other warnings & precautions

WARNINGS Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole and trimethoprim is used during pregnancy, or if the patient b

Sulfamethoxazole And Trimethoprim Black Box Warning

No black box warning on record for Sulfamethoxazole And Trimethoprim

Other warnings & precautions

Sulfamethoxazole And Trimethoprim Black Box Warning

No black box warning on record for Sulfamethoxazole And Trimethoprim

Other warnings & precautions